-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

MediciNova Says Phase 1 Trial Showed Favorable Safety Profile of Intravenous Inflammatory Drug Candidate MN-166

MediciNova Says Phase 1 Trial Showed Favorable Safety Profile of Intravenous Inflammatory Drug Candidate MN-166

MT Newswires · 01/05/2023 23:07